A
Ana Lako
Researcher at Harvard University
Publications - 39
Citations - 2881
Ana Lako is an academic researcher from Harvard University. The author has contributed to research in topics: Immune checkpoint & Cytotoxic T cell. The author has an hindex of 13, co-authored 33 publications receiving 1254 citations. Previous affiliations of Ana Lako include Brigham and Women's Hospital & Bristol-Myers Squibb.
Papers
More filters
Journal ArticleDOI
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Brian C. Miller,Debattama R. Sen,Debattama R. Sen,Rose Al Abosy,Rose Al Abosy,Kevin Bi,Kevin Bi,Yamini V. Virkud,Martin W. LaFleur,Kathleen B. Yates,Kathleen B. Yates,Ana Lako,Kristen Felt,Girish S. Naik,Michael Manos,Evisa Gjini,Juhi R. Kuchroo,Juhi R. Kuchroo,Jeffrey J. Ishizuka,Jeffrey J. Ishizuka,Jenna L. Collier,Gabriel K. Griffin,Gabriel K. Griffin,Gabriel K. Griffin,Seth Maleri,Seth Maleri,Dawn E. Comstock,Dawn E. Comstock,Sarah A. Weiss,Sarah A. Weiss,Flavian D. Brown,Arpit Panda,Arpit Panda,Margaret D. Zimmer,Robert T. Manguso,F. Stephen Hodi,Scott J. Rodig,Scott J. Rodig,Arlene H. Sharpe,W. Nicholas Haining,W. Nicholas Haining +40 more
TL;DR: It is shown that therapy acts on a specific subpopulation of exhausted CD8+ tumor-infiltrating lymphocytes (TILs) that retain polyfunctionality and are responsive to PD-1 blockade.
Journal ArticleDOI
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Romain Guieze,Vivian M. Liu,Daniel Rosebrock,Alexis A. Jourdain,Alexis A. Jourdain,María Hernández-Sánchez,María Hernández-Sánchez,Aina Martinez Zurita,Jing Sun,Jing Sun,Elisa Ten Hacken,Elisa Ten Hacken,Kaitlyn Baranowski,Philip A. Thompson,Jin-Mi Heo,Zachary J. Cartun,Ozan Aygün,J. Bryan Iorgulescu,J. Bryan Iorgulescu,Wandi Zhang,Giulia Notarangelo,Dimitri Livitz,Shuqiang Li,Matthew S. Davids,Matthew S. Davids,Anat Biran,Stacey M. Fernandes,Jennifer R. Brown,Ana Lako,Zoe B. Ciantra,Matthew A. Lawlor,Derin B. Keskin,Derin B. Keskin,Namrata D. Udeshi,William G. Wierda,Kenneth J. Livak,Anthony Letai,Anthony Letai,Donna Neuberg,J. Wade Harper,Steven A. Carr,Federica Piccioni,Christopher J. Ott,Ignaty Leshchiner,Cory M. Johannessen,John G. Doench,Vamsi K. Mootha,Vamsi K. Mootha,Gad Getz,Gad Getz,Catherine J. Wu +50 more
TL;DR: Regulators of lymphoid transcription and cellular energy metabolism are identified as drivers of venetoclax resistance in addition to the known involvement by BCL-2 family members, which were confirmed in patient samples.
Journal ArticleDOI
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
Jonathan D. Schoenfeld,Jonathan D. Schoenfeld,Glenn J. Hanna,Glenn J. Hanna,Vickie Y. Jo,Bhupendra Rawal,Yu-Hui Chen,P.S. Catalano,Ana Lako,Ana Lako,Zoe B. Ciantra,Jason L. Weirather,Shana Criscitiello,Shana Criscitiello,Adrienne M. Luoma,Nicole G. Chau,Jochen H. Lorch,Jochen H. Lorch,Jason I. Kass,Jason I. Kass,Donald J. Annino,Donald J. Annino,Laura A. Goguen,Laura A. Goguen,Anupam M. Desai,Brendan Ross,Brendan Ross,Hina Shah,Heather A. Jacene,Danielle N. Margalit,Danielle N. Margalit,Roy B. Tishler,Roy B. Tishler,Kai W. Wucherpfennig,Scott J. Rodig,Scott J. Rodig,Ravindra Uppaluri,Ravindra Uppaluri,Robert I. Haddad,Robert I. Haddad +39 more
TL;DR: Novel approaches are needed to improve outcomes in patients with squamous cell carcinoma of the oral cavity and promising rates of response in both arms are observed, supporting further neoadjuvant studies with these agents.
Journal ArticleDOI
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Anniina Färkkilä,Doga Gulhan,Julia Casado,Connor A. Jacobson,Huy V. Nguyen,Bose Kochupurakkal,Zoltan Maliga,Clarence Yapp,Yu-An Chen,Denis Schapiro,Yinghui Zhou,Julie R. Graham,Bruce J. Dezube,Pamela N. Munster,Sandro Santagata,Elizabeth P. Garcia,Scott J. Rodig,Ana Lako,Dipanjan Chowdhury,Geoffrey I. Shapiro,Ursula A. Matulonis,Peter J. Park,Sampsa Hautaniemi,Peter K. Sorger,Elizabeth M. Swisher,Alan D. D'Andrea,Panagiotis A. Konstantinopoulos +26 more
TL;DR: An integrated genomic and immunomics analysis of tumor samples from the same patients is performed to find potential predictive biomarkers of response to such combination therapy.
Journal ArticleDOI
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems.
Shahar Alon,Shahar Alon,Shahar Alon,Daniel Goodwin,Daniel Goodwin,Anubhav Sinha,Anubhav Sinha,Asmamaw T Wassie,Asmamaw T Wassie,Fei Chen,Fei Chen,Evan R. Daugharthy,Evan R. Daugharthy,Yosuke Bando,Atsushi Kajita,Andrew G Xue,Karl Marrett,Robert Prior,Yi Cui,Yi Cui,Andrew C. Payne,Andrew C. Payne,Chun-Chen Yao,Chun-Chen Yao,Ho-Jun Suk,Ho-Jun Suk,Ru Wang,Ru Wang,Chih-Chieh Yu,Chih-Chieh Yu,Paul W. Tillberg,Paul Reginato,Nikita Pak,Nikita Pak,Songlei Liu,Songlei Liu,Sukanya Punthambaker,Sukanya Punthambaker,Eswar Prasad Ramachandran Iyer,Richie E. Kohman,Richie E. Kohman,Jeremy A. Miller,Ed S. Lein,Ana Lako,Nicole Cullen,Scott J. Rodig,Karla Helvie,Daniel L Abravanel,Daniel L Abravanel,Nikhil Wagle,Bruce E. Johnson,Johanna Klughammer,Michal Slyper,Julia Waldman,Judit Jané-Valbuena,Orit Rozenblatt-Rosen,Aviv Regev,Aviv Regev,Aviv Regev,George M. Church,George M. Church,Adam H. Marblestone,Edward S. Boyden +62 more
TL;DR: In this paper, the authors applied untargeted expansion sequencing (ExSeq) to the mouse brain, which yielded the readout of thousands of genes, including splice variants, revealing patterns across multiple cell types, layer-specific cell types across the mouse visual cortex, and the organization and position dependent states of tumor and immune cells in a human metastatic breast cancer biopsy.